Jinyu Bio-technology Co., Ltd. (600201.SS)
- Previous Close
9.11 - Open
8.95 - Bid 8.91 x --
- Ask 8.92 x --
- Day's Range
8.73 - 8.99 - 52 Week Range
6.94 - 11.59 - Volume
18,858,446 - Avg. Volume
14,118,225 - Market Cap (intraday)
9.982B - Beta (5Y Monthly) 0.58
- PE Ratio (TTM)
34.27 - EPS (TTM)
0.26 - Earnings Date --
- Forward Dividend & Yield 0.06 (0.66%)
- Ex-Dividend Date Jun 21, 2023
- 1y Target Est
9.85
Jinyu Bio-technology Co., Ltd. engages in the research and development, production, and sale of veterinary products in China. Its product portfolio includes Jinyu Baoling, Yangzhou Youbang, and Liaoning Yikang animal vaccines for the prevention of foot, porcine, mycoplasma pneumoniae, porcine reproductive and respiratory syndrome, porcine pseudorabies, pathogenic avian influenza, brucellosis bacterial disease, bovine viral diarrhea and mucosal, infectious rhinotracheitis, and other domestic animal diseases. The company was founded in 1992 and is headquartered in Hohhot, China.
www.jinyu.com.cnRelated News
Performance Overview: 600201.SS
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600201.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600201.SS
Valuation Measures
Market Cap
9.98B
Enterprise Value
8.27B
Trailing P/E
34.27
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.13
Price/Book (mrq)
1.82
Enterprise Value/Revenue
5.23
Enterprise Value/EBITDA
26.65
Financial Highlights
Profitability and Income Statement
Profit Margin
17.62%
Return on Assets (ttm)
2.81%
Return on Equity (ttm)
5.11%
Revenue (ttm)
1.64B
Net Income Avi to Common (ttm)
288.91M
Diluted EPS (ttm)
0.26
Balance Sheet and Cash Flow
Total Cash (mrq)
1.85B
Total Debt/Equity (mrq)
0.01%
Levered Free Cash Flow (ttm)
408.04M
Research Analysis: 600201.SS
Company Insights: 600201.SS
600201.SS does not have Company Insights